Moderna to Host Science Day Investor Event Highlighting mRNA Platform Expansion with AI and Robotics
核心洞察
Moderna announced it will host its Investor Event – Science Day on June 25, 2026, at 9:00 a.m. ET, featuring a live webcast accessible via the company's investor relations website.
The event will showcase Moderna's research and early development programs, emphasizing how its mRNA platform combined with AI and robotics is accelerating innovation.
The presentation aims to highlight opportunities for Moderna to expand into new therapeutic areas beyond its current infectious disease and oncology portfolios.
Moderna, Inc. (Nasdaq: MRNA) announced on June 17, 2026, that it will host its Investor Event – Science Day on Thursday, June 25, 2026, at 9:00 a.m. Eastern Time. The Cambridge, Massachusetts-based biotechnology company will use the event to provide an overview of its research and early development programs, with a particular focus on how its mRNA platform is being enhanced through advances in artificial intelligence and robotics.
The event represents a strategic opportunity for Moderna to communicate its pipeline evolution to the investment community. According to the company's announcement, the presentation will highlight how the convergence of mRNA technology with AI and robotics is accelerating innovation and creating opportunities to expand into new therapeutic areas.
Moderna has established itself as a pioneer in the field of mRNA medicine. Since its founding, the company's mRNA platform has enabled the development of vaccines and therapeutics spanning infectious diseases, cancer, and rare diseases. The upcoming Science Day signals the company's intent to broaden its therapeutic footprint further, leveraging computational and automation technologies to enhance its drug discovery and development capabilities.
A live webcast of the presentation will be available under "Events and Presentations" in the Investors section of the Moderna website at investors.modernatx.com. For those unable to attend the live session, a replay of the webcast will be archived on Moderna's website for at least 30 days following the presentation.
Lavina Talukdar, Senior Vice President and Head of Investor Relations at Moderna, serves as the contact for investor inquiries related to the event.